Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer
Jinju Oh, Ki Ho Seol, Hyun Joo Lee, Youn Seok Choi, Ji Y. Park, Jin Young Bae
Radiat Oncol J. 2017;35(4):349-358.   Published online 2017 Dec 23     DOI:
Citations to this article as recorded by Crossref logo
Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?
Won Kyung Cho, Won Park, Hakyoung Kim, Yeon Joo Kim, Young Seok Kim
Taiwanese Journal of Obstetrics and Gynecology.2022; 61(2): 329.     CrossRef
The best postoperative adjuvant therapy for patients with early stage cervical adenosquamous carcinoma
Yawen Liu, Haiyan Tu, Lingling Zhang, Meiling Zhong, Yanan Wang, Ling Li, Xiaojun Xiang
BMC Women's Health.2022;[Epub]     CrossRef
The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis
Leslie J.H. Bukkems, Ina M. Jürgenliemk-Schulz, Femke van der Leij, Max Peters, Cornelis G. Gerestein, Ronald P. Zweemer, Peter S.N. van Rossum
Clinical and Translational Radiation Oncology.2022; 35: 97.     CrossRef
Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06)
Nalee Kim, Won Park
Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
Para-Aortic Nodal Radiation in the Definitive Management of Node-Positive Cervical Cancer
Jason C. Sanders, Donald A. Muller, Sunil W. Dutta, Taylor J. Corriher, Kari L. Ring, Timothy N. Showalter, Kara D. Romano
Frontiers in Oncology.2021;[Epub]     CrossRef
Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost
Haeyoung Kim, Won Park, Won Kyung Cho
Journal of Radiation Research.2020; 61(3): 479.     CrossRef
Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer
Won Kyung Cho, Yeon Joo Kim, Hakyoung Kim, Young Seok Kim, Won Park
Japanese Journal of Clinical Oncology.2020; 50(10): 1150.     CrossRef
Prophylactic Extended-Field Irradiation in Patients With Cervical Cancer: A Literature Review
Weiping Wang, Yuncan Zhou, Dunhuang Wang, Ke Hu, Fuquan Zhang
Frontiers in Oncology.2020;[Epub]     CrossRef
Radiochemotherapie des Zervixkarzinoms
S. Marnitz, J. Morgenthaler, S. Kunze, J. Herter
Der Onkologe.2019; 25(6): 543.     CrossRef
Multi-institutional Observational Study of Prophylactic Extended-Field Concurrent Chemoradiation Therapy Using Weekly Cisplatin for Patients With Pelvic Node-Positive Cervical Cancer in East and Southeast Asia
Masaru Wakatsuki, Shingo Kato, Tatsuya Ohno, Parvin Akhter Banu, Nguyen Cong Hoang, Erdenetuya Yadamsuren, Nana Supriana, Jianping Cao, C.R. Beena Devi, Miriam Joy Calaguas, Yaowalak Chansilpa, Chul-Koo Cho, Tasbolat Adylkhanov, Noriyuki Okonogi, Takashi
International Journal of Radiation Oncology*Biology*Physics.2019; 105(1): 183.     CrossRef
Radiochemotherapie oder operative Therapie bei Zervixkarzinom – was und zu welcher Zeit?
Simone Marnitz, Dennis Akuoma-Boateng, Jan Herter
Der Gynäkologe.2019; 52(8): 587.     CrossRef
Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis
Weiping Wang, Xiaoliang Liu, Qingyu Meng, Fuquan Zhang, Ke Hu
International Journal of Gynecologic Cancer.2018; 28(8): 1584.     CrossRef